Pergolide (Equine)
Generic: Pergolide mesylate
Pergolide mesylate is a potent dopamine receptor agonist primarily used in the management of Pituitary Pars Intermedia Dysfunction (PPID) in horses.
This medication is intended for horses.
Overview
Pergolide mesylate is the gold-standard pharmacological treatment for horses diagnosed with Pituitary Pars Intermedia Dysfunction (PPID), formerly known as equine Cushing’s disease. PPID is a progressive neurodegenerative disorder caused by the loss of dopaminergic inhibition of the pituitary pars intermedia, leading to an overproduction of pro-opiomelanocortin (POMC)-derived peptides. By functioning as a dopamine receptor agonist, Pergolide helps restore the neurological balance required to regulate hormone production in the pituitary gland. While Levothyroxine (Equine) is sometimes considered for other endocrine issues like hypothyroidism in horses, Pergolide remains the specific therapy for PPID-related pituitary dysfunction. Clinical use is often lifelong, as the condition is degenerative and not curative. Unlike Trilostane, which is used for Cushing's in small animals, Pergolide addresses the specific neuro-endocrine feedback loop found in equines. Veterinarians typically monitor horses using baseline ACTH testing and seasonal adjustment to ensure the dosage remains effective throughout the year, as hormonal fluctuations are highly sensitive to photoperiod changes. Managing endocrine disorders can be complex, and practitioners must distinguish between PPID and other metabolic conditions like equine metabolic syndrome (EMS). Owners should note that Selegiline has historically been studied in horses but lacks the efficacy of Pergolide in treating clinical signs of PPID. Furthermore, other endocrine therapies such as Carbimazole or Mitotane are not indicated for use in horses with this condition. The goal of therapy is to alleviate clinical signs such as hirsutism, laminitis, and muscle wasting, thereby improving the horse's overall quality of life.
What It Treats
- Pituitary Pars Intermedia Dysfunction (PPID): The primary condition characterized by hormonal imbalances due to pituitary gland changes.
- Hirsutism: Treats the failure to shed the winter coat associated with PPID.
- Laminitis: Helps manage chronic or recurrent laminitis secondary to uncontrolled hormonal levels in PPID patients.
- Muscle Wasting: Addresses the loss of topline and muscle mass caused by abnormal cortisol and ACTH metabolism.
- Polyuria/Polydipsia: Reduces excessive drinking and urination often seen in advanced cases.
How It Works
Pergolide mesylate is a synthetic ergoline derivative that acts as a potent dopamine receptor agonist. In the healthy equine brain, dopamine is released by neurons in the hypothalamus to inhibit the production of hormones in the pituitary pars intermedia. In horses with PPID, these neurons undergo oxidative stress and degenerate, leading to a deficiency in dopamine and subsequent over-secretion of hormones like ACTH. By supplementing the dopamine levels, Pergolide stimulates D2 receptors, effectively 'switching off' the abnormal pituitary output.
Dosage
Dosage is highly individualized and must be strictly determined by your veterinarian. Treatment typically begins at a low dose (often 0.002 mg/kg) and is titrated upward based on clinical response and ACTH blood levels. Never adjust the dosage without veterinary supervision, as the drug's effect varies significantly between individual horses.
Administration
Pergolide is generally administered once daily, either directly into the mouth or mixed with a small amount of food. Consistency in timing is essential to maintain steady blood levels. If the horse is a picky eater, tablets can be crushed and mixed with a small volume of water or applesauce, but ensure the entire dose is consumed to ensure therapeutic efficacy.
Storage
Store Pergolide at room temperature, typically between 68°F and 77°F (20°C to 25°C). Keep the medication in a tightly closed, light-resistant container, as the drug can be sensitive to environmental degradation. Ensure it is kept in a secure location out of reach of children and other animals.
Contraindications
Pergolide should not be used in horses with a known hypersensitivity to pergolide mesylate or other ergot derivatives. It should be used with extreme caution in pregnant or lactating mares, as the drug can inhibit prolactin release, potentially affecting the mare's ability to produce milk or induce labor. It is also not indicated for horses that do not have a confirmed diagnosis of PPID through endocrine testing.
Interactions
Pergolide should be used cautiously with dopamine antagonists, such as tranquilizers like acepromazine or certain prokinetic agents like metoclopramide, as these drugs may negate the therapeutic effects of Pergolide. Additionally, combination with other drugs that impact central nervous system function should be closely monitored by a veterinarian. Always inform your clinician of any supplements or medications the horse is receiving.
Side Effects
- Decreased appetite or anorexia
- Lethargy or depression
- Colic symptoms
- Diarrhea
- Behavioral changes (e.g., nervousness or aggression)
- Ataxia (in rare cases)
Sources & References
Frequently Asked Questions
This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.